Perioperative blood transfusion in the neoplastic patient. I. Immunological alterations and clinical consequences;Transfusión sanguínea perioperatoria en el paciente neoplásico. I. Alteraciones inmunológicas y consecuencias clínicas

Cirugia Espanola

Volumn 72, Issue 3, 2002, Pages 160-168

  Muñoz Gómez, Manuel ^a   Llau Pitarch, Juan Vicente ^b   Leal Noval, Santiago Ramón ^c   García Erce, José Antonio ^d   Culebras Fernández, Jesús Manuel ^e  

^a GIEMSA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^e HOSPITAL DE LEÓN   (Spain)

Author keywords

Allogenic transfusion; Oncological surgery; Postoperative infection; Storage lesion; Th2 response; TRIM; Tumoral recurrence

Indexed keywords

EID: 12144256265     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/S0009-739X(02)72032-0     Document Type: Review

References (88)

1. Ruiz MD, Pascual NJ, Muñoz MI, Maldonado J, García G, Maldonado Eloy-García J. Efectos adversos de las transfusiones. En: Muñoz M, coordinador. Autotransfusión y otras alternativas al uso de sangre homóloga en cirugía. Málaga: SPICUM, 1999; p. 69-84.
2. Fariñas F, Muñoz M, García-Vallejo JJ, Ruiz MD, Morell M. Inmunodepresión inducida por transfusión de sangre homóloga. Sangre 1998;43:213-7.
3. Klein HG. Immunomodulatory aspects of transfusion. Anesthesiology 1999;91;861-5.
4. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine: first of two parts-blood transfusion. N Engl J Med 1999;340:438-47.
5. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood 2001; 97:1180-95.
6. Blumberg N, Heal JM. The transfusion immunomodulation theory: the Th1/Th2 paradigm and an analogy with pregnance as a unifying mechanism. Semin Hematol 1996;33:328-40.
7. Blajchman MA. Immunomodulatory effects of allogenic blood transfusion: clinical manifestations and mechanisms. Vox Sang 1998; 74(Suppl 2):315-9.
8. Leal SR, Jara I, Román MJ. Transfusión de concentrado de hematíes e infección posquirúrgica en pacientes críticos. Med Clin (Barc) 2000;115:625-9.
9. Lanzavecchia A. Identifying strategies for immune intervention. Science 1993;260:937-44.
10. Mincheff MS, Meryman HT. Blood transfusion, blood storage and immunomodulation. Immunol Invest 1995;24:303-9.
11. Mincheff MS. Changes in donor leukocytes during blood storage. Implications on post-transfusion immunomodulation and transfusion-associated GVHD. Vox Sang 1998;74(Suppl 2):189-200.
12. Claas FHJ, Lagaay EL, Van Rood JJ. Immunological consequences of blood transfusions. Schweiz Med Wschr 1991;121(Suppl 43): 70-2.
13. Verove C, Jollet I, Lobbedez T, Dumont G, Griveau AM, Hurault de Ligny B, et al. Compared effects of random and one HLA semi-identical transfusions on alloinmunization and acute rejection episodes in first renal allograft recipients. Transplant Proc 1998;30:2863-4.
14. Blajchman MA, Bardossy L, Carmen R. Allogeneic blood transfusion-induced enhancement of tumour growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood 1993;81:1880-2.
15. Nielsen HJ, Reimer CM, Pedersen AN, Brünner N, Edvardsen L, Dybkjaer E, et al. Time-dependent, spontaneous release of white cell-and platelet-derived bioactive substance from stored human blood. Transfusion 1996;36:960-5.
16. Vliet WC, Drock NL, Davey FR. Factors in the liquid portion of stored blood inhibit the proliferative response in mixed lymphocytes cultures. Transfusion 1989;29:41-5.
17. Ross WB. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993;329:1354-5.
18. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994;15:575-81.
19. Babcock GF, Alexander JW. The effect of blood transfusion on cytokine production Th1 and Th2 lymphocytes in the mouse. Transplantation 1996;61:465-8.
20. Kalechman Y, Gafter U, Sobelman D. The effect of a single whole blood transfusion on cytokine secretion. J Clin Immunol 1990;10:99-105.
21. Mynster T, Dybkjoer E, Kronborg G, Nielsen HJ. Immunomodulating effect of blood transfusion: is storaged time important? Vox Sang 1998;74:176-81.
22. Heiss MM, Farunberger P, Delanoff C, Stets R, Allgayer H, Strohlein MA, et al. Modulation of immune response by blood transfusion: evidence for a differential effect of allogenic and autologous blood in colorectal cancer surgery. Shock 1977;8:402-8.
23. Heiss MM, Fasol-Merten K, Allgayer H, Strohlein MA, Tarabichi A, Wallner S, et al. Influence of autologous blood transfusion on natural killer and lymphokine-activated killer cell activities in cancer surgery. Vox Sang 1997;73:237-45.
24. Isaacs KL, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992;103:1587-95.
25. Peters WR, Fry RD, Fleshman JW, Kodner IJ. Multiple blood transfusion reduce the recurrence rate of Crohn's disease. Dis Colon Rectum 1989;32:749-53.
26. Peña AS. Patogenia de la enfermedad inflamatoria intestinal. Rev Gastroenterol 1998;1:390-403.
27. Carson JL, Altman DG, Duff A, Noveck H, Weinstein MP, Sonenberg FA, et al. Risk of bacterial infection associated with allogenic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999;39:694-700.
28. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg 1999;81-A:2-10.
29. Leal SR, Márquez JA, García-Curiel A, Camacho P, Rincón MD, Ordóñez A, et al. Nosocomial pneumonia in patients undergoing heart surgery. Crit Care Med 2000;28:935-40.
30. Leal-Noval SR, Rincon-Ferrari MD, García-Curiel A, Herruzo-Avilés A, Camacho-Larana P, Garnacho-Montero J, et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 2001;119:1461-8.
31. Jensen LS, Andersen AJ, Christensen PM, Hokland P, Juhl CO, Madsen G, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513.
32. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leukocyte-depleted versus buffy-coat-poor blood transfusion on infectious complication after colorectal surgery. Lancet 1996;348:841-5.
33. Houbiers JG, Van de Velde CJ, Van de Watering LM, Hermans J, Schreuder S, Bijnen AB, et al. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion 1997;37:126-34.
34. Tatter PI, Mohandas K, Azar P, Endres J, Kaplan J, Spivack M. Randomised trial comparing packed red blood cell transfusion with or without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998;176:462-6.
35. Wether K, Christensen IJ, Nielsen HJ, Danish RANX05 Colorectal Cancer Study Group. The association between preoperative concentration of soluble vascular endotelial growth factor, perioperative blood transfusion, and survival in patients with primary colorectal cancer. Eur J Surg 2001;167:287-92.
36. Wichman MW, Müller C, Hornung HM, Lau-Werner U, Schilberg FW, Colorectal Cancer Study Group. Gender differences in long-term survival of patients with colorectal cancer. Br J Surg 2001;88:1092-8.
37. Nozoe T, Matsumata T, Kitamura M, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis incolorectal cancer. Am J Surg 1998;176:335-8.
38. Nielsen HJ, Pappot H, Christensen IJ, Brünner N, Thorlacius-Ussing O, Moesgaard F, et al. Assocciation between plasma concentration of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer. BMJ 1998;316: 829-30.
39. Nozoe T, Matsumata T, Sugimachi K. Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer. Am J Clin Oncol 2000;23:263-6.
40. Wigmore SJ, McMahon AJ, Sturgeron CM, Fearon KC. Acute-phase response, survival and tumour recurrence in patients with colorectal cancer. Br J Surg 2001;88:255-60.
41. Nielsen HJ, Christensen IJ, Sorensen S, Moesgaard F, Brünner N. Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. Ann Surg Oncol 2000;7:617-23.
42. Edna TH, Bjerkeset T. Association between transfusión of stored blood and infective bacterial complications after resection for colorectal cancer. Eur J Surg 1998;164:449-56.
43. Edna TH, Bjerkeset T. Perioperative blood transfusion reduce longterm survival following surgery for colorectal cancer. Dis Colon Rectum 1998;41:451-9.
44. Nielsen HJ, Edvardsen L, Vangsgaard K, Dybkjaer E, Skov PS. Time-dependent histamine release from stored human blood products. Br J Surg 1996;83:259-62.
45. Kristiansson M, Soop M, Shanwell A, Sundqvist KG. Prestorage versus bedside white blood cell filtration of red blood cell concentrates: effects on the content of cytokines and soluble tumor necrosis factor receptors. J Trauma 1996;40:379-83.
46. Weisbach V, Wanke C, Zingsem J, Zimmermann R, Eckstein R. Cytokine generation in whole blood, leukocyte-depleted and temporarily warmed red blood cell concentrates. Vox Sang 1999;76: 100-6.
47. Jacobi KE, Wanke C, Jacobi A, Weisbach V, Hemmerling TM. Determination od eicosanoid and cytokine production in salvaged blood, stored red blood cells concentrates, and whole blood. J Clin Anesth 2000;12:94-9.
48. Phipps RP, Kaufman J, Blumberg N. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet 2001;357: 2023-4.
49. Muñoz M, Sánchez Y, García-Vallejo JJ, Mérida FJ, Ruiz MD, Maldonado J. Autotransfusión pre y postoperatoria. Estudio comparativo de la hematología, bioquímica y metabolismo eritrocitario en sangre predonada y sangre de drenaje postoperatorio. Sangre 1999;44:443-50.
50. Messana I, Ferroni L, Misisti F, Girelli G, Pupella S, Castagnola M, et al. Blood bank conditions and RBCs: the progressive loss of metabolic modulation. Transfusion 2000;40:353-60.
51. Low PS, Willardson BM, Mohandas N. Contribution of band 3-ankyrin interaction to erythrocyte membrane mechanical stability. Blood 1991;77:1581-6.
52. Moriyama R, Lombardo CR, Workman RF, Low PS. Regulation of linkages between the erythrocyte membrane and its skeleton by 2,3-diphosphoglycerate. J Biol Chem 1993;268:10990-6.
53. Rasia A, Bolini A. Red blood cell shape as a function of medium's ionic strength and pH. Biochim Biophys Acta 1998;1372:198-204.
54. Wilson MJ, Richter-Lowney K, Daleke DL. Hyperglucemia induces a loss of phospholipid asymmetry in human erythrocytes. Biochemistry 1993;32:11302-10.
55. Closse C, Dachary-Prigent J, Boisseau MR. Phosphatidylserine-related adhesión of human erythrocyte to vascular endothelium. Br J Haematol 1999;107:300-2.
56. Eichelbronner O, Sielenkamper A, Cepinskas G, Sibbald WJ, Chin-Yee IH. Endotoxin promotes adhesion of human erythrocytes to human vascular endothelial cells under conditions of flow. Crit Care Med 2000;28:1865-70.
57. Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxigen delivery in patients with sepsis. JAMA 1993;269:3024-9.
58. Fitzgerald RD, Martin C, Dietz GE, Doig GS, Potter RF, Sibbald WJ. Transfusing red blood cells stored in citrate phosphate dextrose adenine-1 for 28 days fails to improve tissue oxygenation in rats. Crit Care Med 1997;25:726-32.
59. Hopf HW, Hunt TK, West JM, Blomquist P, Goodson WH, Jensen JA, et al.Wound tissue tesion predicts the risk of wound infection in surgical patients. Arch Surg 1997;132:997-1004.
60. Saadia R, Schein M, MacFarlane C, Boffard KD. Gut barrier function and the surgeon. Br J Surg 1990;77:487-92.
61. Alexander JW, Boyce ST, Babcock GF, Gianotti L, Peck MD, Dunn DL, et al. The process of microbial translocation. Ann Surg 1990; 212:496-510.
62. Mynster T, Nielsen HJ. The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery. Danish RANX05 Colorectal Cancer Study Group. Scand J Gastroenterol 2000;35:212-7.
63. Vamvakas EC, Carven JH. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery. Effect of the lenght of storage of transfused red cells. Transfusion 1999;39:701-10.
64. Fransen E, Maessen J, Dentener M, Senden N, Baurman W. Impact of blood transfusion on inflammatory mediators release in patients undergoing cardiac surgery. Chest 1999;116:1233-9.
65. Silliman CC, Paterson AJ, Dickey WO, Stroncek DF, Popovsky MA, Cadwell SA, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 1997;37:719-26.
66. Silliman CC, Volekel NF, Allard JD, Elzi DJ, Tuder RM, Johnson JL, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 1998;101:1458-67.
67. Faraday N, Scharp RB, Doddo JM, Martínez EA, Rosenfeld B, Dorman T. Leukocytes can enhance platelet-mediated aggregation and thromboxane release via interaction of P-selectin gly-coprotein ligand 1 with P-selectin. Anesthesiology 2001;94:145-51.
68. Zhang XF, Feng MF. Adherence of human monocytes and NK cells to human TNFa-stimulated porcine endothelial cells. Immunol Cell Biol 2000;78:633-40.
69. Van de Watering LMG, Brand A, Houbiers JGA, Klein Kranenbarg WM, Hermans J, Van de Velde CJH. Perioperative blood transfusions, with or without allogeneic leucocytes, relates to survival, not to cancer recurrence. Br J Surg 2001;88:267-72.
70. Mynster T, Christensen IJ, Moesgaard F, Nielsen HJ. Effects of the combination of blood transfusión and postoperative infectious complications on prognosis after surgery for colorectal cancer. Br J Surg 2000;87:1553-62.
71. Nielsen HJ, Werther K, Mynster T, Svendsen MN, Rosendahl S, Elley T, Skov F. Bacteria-induced release of white cell-and plateletderived vascular endothelial growth factor in vitro. Vox Sang 2001; 80:170-8.
72. Nielsen HJ, Werther K, Mynster T, Brünner N. Soluble vascular endothelial growth factor in various blood transfusion components. Transfusion 1999;39:1078-83.
73. Zachary I. Vascular endothelial growth factor. Int J Biochem Cell Biol 1998;30:1169-74.
74. Lennard CM, Patel A, Wilson J, Reinhardt B, Tuman C, Fenton C, et al. Intesity of vascular endothelial growth factor expressión is associated with increased risk of recurrence and decrease disease-free survival in papillary thyroid cancer. Surgery 2001;129:552-8.
75. Shawver LK, Slamon D, Ullrich A. Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 2002;1:117-23.
76. Culebras JM, De Paz R, Jorquera F, García de Lorenzo A. Nutrición en el paciente quirúrgico: inmunonutrición. Nutr Hosp 2001;16:67-77.
77. Navarro M. Inmunomodulación en cirugía. En: Navarro M, director. Aspectos inmunológicos de la cirugía. Zaragoza: Prensas Universitarias de Zaragoza, 1997; p. 301-31.
78. López-Andrade A, Almazán A, Martín JL, Samaniego F, López-Andrade MA, Del Campo A. Respuesta inmune en el paciente quirúrgico: influencia de la anestesia y la transfusión sanguínea. Rev Esp Anestesiol Reanim 2000;47:67-80.
79. Salas J, De Vega N, Carmona J, Negri S, García-Vallejo JJ, Muñoz M. Autotransfusión postoperatoria en cirugía cardíaca. Características hematológicas, bioquímicas e inmunológicas de la sangre recuperada del drenaje mediastínico. Rev Esp Anestesiol Reanim 2001;48:122-30.
80. Sebastián C, Romero R, Olalla E, Ferrer C, García-Vallejo JJ, Muñoz M. Postoperative blood salvage and reinfusion in spinal surgery. Blood quality, effectiveness and impact on patient blood parameters. Eur Spine J 2000;9:458-65.
81. Ruiz MD, Maldonado Taillefer J, Muñoz M, Maldonado J. Modificaciones de las subpoblaciones linfocitarias en respuesta a la cirugía. En: Muñoz M, coordinador. Respuestas del sistema inmunitario a la cirugía. Málaga: SPICUM, 2001; p. 97-121.
82. Navarro-Zorraquino M, Lozano R, Deus J, Pastor C, Larrad L, Tejero E, et al. Determination of the immunoglobulin E postoperative variation as a measure of surgical injury. World J Surg 2001;25: 585-91.
83. Algora M, Fernández A, Gómez JL, Martín C, Prats I, Puig N, et al. Guía sobre la indicación de la transfusión de glóbulos rojos, plaquetas y productos plasmáticos lábiles. Med Clin (Barc) 1999;113: 471-4.
84. Fernández Montoya A. Variaciones de la práctica de la transfusión en España. Sangre 1999;44:30-7.
85. Llau JV, Sánchez AM. Práctica transfusional entre los anestesiólogos en España. Rev Esp Anestesiol Reanim 1998;45:226-32.
86. Llau JV. Medicina transfusional perioperatoria. Rev Esp Anestesiol Reanim 2002;48:103-5.
87. García-Caballero M, García-Vallejo JJ, Muñoz M. Medidas no farmacológicas de ahorro de sangre en cirugía. Cir Esp 1999;66: 250-5.
88. García-Caballero M, Gómez A, Pavía J, Villalobos JA, García-Vallejo JJ, Muñoz M. Medidas farmacológicas de ahorro de sangre en cirugía. Cir Esp 2001;69:146-58.